Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2023-11-03 2024-01-19 209145
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2022-05-19 2022-06-09 160994
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2022-08-18 2023-07-05 167156
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2022-08-18 2023-10-06 167197
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2020-03-06 2020-03-19 107964
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2020-04-02 2020-06-04 110679
TEVA-BUDESONIDE 0.125MG SUSPENSION Actual shortage 2024-08-08 2025-04-24 234891
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2021-03-11 2021-04-15 135558
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2021-04-29 2021-08-07 138291
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2021-06-03 2021-10-14 140390
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-05-20 2021-06-03 139725
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-06-03 2021-06-10 140363
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2022-12-01 2022-12-22 176824
TEVA-BUPRENORPHINE/NALOXONE 0.5MG 2MG TABLET Resolved 2021-08-27 2021-09-16 144704
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2024-03-07 2024-06-27 221534
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2024-03-07 2024-06-27 221537
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215743
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215746
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-06-07 223856

Showing 861 to 880 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-03-20 2025-03-20 253165
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2024-10-11 2024-10-11 240081
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350
TEVA-NORFLOXACIN 400MG TABLET Discontinued 2018-10-19 2018-10-19 65013
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63946
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63949
TEVA-NYSTATIN 100000UNIT CREAM Discontinued 2020-07-10 2020-07-10 120056
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-06-28 2024-06-29 231586
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-10-11 2024-10-11 240078
TEVA-PANTOPRAZOLE MAGNESIUM 40MG TABLET (DELAYED-RELEASE) Discontinued 2021-02-12 2021-02-12 133891
TEVA-PAROXETINE 10MG TABLET Discontinued 2025-03-20 2025-03-20 253182
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313
TEVA-PAROXETINE 20MG TABLET Discontinued 2025-03-20 2025-03-20 253160
TEVA-PAROXETINE 30MG TABLET Discontinued 2019-12-09 2019-12-09 100540
TEVA-PAROXETINE 20MG TABLET Discontinued 2019-12-09 2019-12-09 100547
TEVA-PAROXETINE 10MG TABLET Discontinued 2020-02-21 2020-02-21 106898
TEVA-PAROXETINE 30MG TABLET Discontinued 2020-02-21 2020-02-21 106901
TEVA-PIOGLITAZONE 45MG TABLET Discontinued 2018-10-19 2018-10-19 65033

Showing 221 to 240 of 299